 |
 |
 |
 |
 |
 |
 |
|
GlycoAdvance technology uses enzymes to complete the sugar chains on glycoprotein drugs that have been produced using conventional mammalian cell culture. Completion of sugar chains protects glycoprotein drugs from rapid uptake by the liver, assuring the longest possible half-life for the secreted molecule.
|
)
GlycoAdvance also has the potential to improve proteins produced in other expression systems, where it can be used to remodel the glycan structure to resemble a human glycoprotein.
|
)
To learn more about how our GlycoAdvance technology works, view the Normal Process and GlycoAdvance movies.
| Normal
Process Movie |
|
|
|
 |
| GlycoAdvance™
Movie |
|
|
|
|
©2002
Neose Technologies, Inc. All Rights Reserved
Print right
half of page content
Print right
half of page content